Business Services

The latest news and analysis of the pharmaceutical and biotech business landscape. Including staff moves, product launches, acquisitions, mergers, collaborations and licensing agreements.

Showing 15 posts of 2322 posts found.

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023 Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery

Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …

Abbott to acquire Bigfoot Biomedical

September 6, 2023 Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes

Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …

Novo Nordisk acquires Embark Biotech and its lead metabolic programme

August 31, 2023 Business Services Cardiology, Novo Nordisk, Obesity, acquisition, metabolics, obesity

Novo Nordisk has officially acquired the biopharmaceutical company Embark Biotech, along with its lead asset metabolic programme. The teams will …

CN Bio introduces Dr Tomasz Kostrzewski as new chief scientific officer

August 31, 2023 Business Services CN Bio, CSO, Dr Tomasz Kostrzewski, Microbiology

On 30August 2023, CN Bio announced the appointment of Dr Tomasz Kostrzewski as chief scientific officer (CSO) – a new …

LEO Pharma to acquire Timber Pharmaceuticals for up to $36m

August 22, 2023 Business Services Dermatology, LEO Pharma, Timber Pharmaceuticals, acquisition

Timber Pharmaceuticals has announced that it has entered a definitive agreement to be acquired by LEO Pharma, with a total …

Destiny Pharma appoints new CEO Chris Tovey

August 21, 2023 Business Services CEO, Chris Tovey, Destiny Pharma, Infections and infestations

Destiny Pharma has announced the appointment of Chris Tovey, who will be replacing Dr Debra Barker as chief executive officer; …

Dr Michael Lutz appointed as new chief executive officer of iotaSciences

August 18, 2023 Business Services Dr Michael Lutz, Haematology, chief executive officer, iotasciences

The pharmaceutical discovery company iotaSciences has announced that it has appointed Dr Michael Lutz as its new chief executive officer. …

Foghorn Therapeutics appoints Alfonso Quintás-Cardama as new chief medical officer

August 18, 2023 Business Services Alfonso Quintas-Cardama, Foghorn Therapeutics, Haematology, chief medical officer

The biotechnology company Foghorn Therapeutics has announced the addition of the new chief medical officer, Alfonso Quintás-Cardama, who will be …

Sunbird Bio and Glympse Bio merge for development of protein-based diagnostic technology

August 10, 2023 Business Services Glympse Bio, Oncology, Sunbird Bio, merger, oncology

Sunbird Bio has announced that it has completed a merger with Glympse Bio, intending to accelerate the development of both …

Astellas set to open new life sciences facilities in Cambridge, Massachusetts

August 10, 2023 Business Development Astellas Pharma, Pharmacy, pharmaceutical, science facility

On 9 August 2023, Astellas Pharma announced its plans to open what it has described as a “state-of-the-art life sciences …

EureKING planning creation of new biotech company through the acquisition of SCTbio

August 9, 2023 Business Services, Research and Development Pharmacy

On 9 August 2023, eureKING announced it is set to acquire the pharmaceutical company SCTbio which specializes in cell and …

Astex expands collaboration with MSD

August 8, 2023 Business Services Astex pharmaceuticals, Merck, Oncology, collaboration, small molecules

Astex Pharmaceuticals has announced an exclusive worldwide research collaboration and license agreement with MSD (known as Merck in the US), …

Ionis and Novartis partner for CVD treatment programme

August 4, 2023 Business Services Cardiology, Ionis Pharmaceuticals, License Agreement, Novartis, cvd

Ionis Pharmaceuticals has announced that it has entered into a new collaboration and license agreement with Novartis, aiming to discover, …

Biogen to acquire Reata Pharmaceuticals

July 31, 2023 Business Services Biogen, Neurology, Reata Pharmaceuticals, acquisition

Biogen and Reata Pharmaceuticals have announced that they have entered a definitive agreement under which Biogen will acquire Reata for …

Renibus Therapeutics announces $47m financing for phase 3 trial

July 19, 2023 Business Services Cardiology, Financing, Renibus Therapeutics, clinical trial

Clinical stage biopharmaceutical company Renibus Therapeutics has announced that it has raised $47m from the initial closing of its Series …

Latest content